𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Passive transfer of contact hypersensitivity to rubber following allogeneic bone marrow transplantation

✍ Scribed by T.W. Lucke; J.L. Bong; D. Clark; J.A. Murphy


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
135 KB
Volume
141
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Passive donor-to-recipient transfer of a
✍ D.S. Ritchie; A. Sainani; A. D'Souza; A.P. Grigg πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 61 KB

Autoantibody production following allogeneic stem-cell transplantation is common and is often ascribed to the immune dysregulation associated with graft-versus-host disease. Recent data suggests that donor-memory B cells can be reactivated on exposure to antigen and result in antibody production in

Regeneration of humoral immunity to herp
✍ J. Z. Wimperis; N. J. Berry; H. Grant Prentice; A. Lever; P. D. Griffiths; Dr. M πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 415 KB

We investigated the adoptive transfer of immunity to herpes simplex virus (HSV) in 61 recipients of T-cell-depleted marrow allografts. Up to 3 months after bone marrow transplantation (BMT), high titres of HSV antibody (Ab) are passively acquired from blood products. This antibody has a half-life of

Transfer of humoral immunity against cyt
✍ Donna M. Roy; Malcolm K. Brenner; Derek Cook; R. Ian Duncan; Paul D. Griffiths; πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 797 KB

## Abstract Previous work by Grob et al. [__Lancet__ i:774, 1987] has demonstrated that allogeneic, T‐cell‐depleted bone marrow transplant recipients have a better prognosis for reactivated cytomegalovirus (CMV) infection if their donor is also immune. It was proposed that adoptively transferred hu

Adoptive transfer of immunity to hepatit
✍ Yaron Ilan; Arnon Nagler; Ruth Adler; Elizabeth Naparstek; Reuven Or; Shimon Sla πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 681 KB

Recipients of allogeneic bone marrow transplantation are pancytopenic for several weeks and immunosuppressed for many months as a result of myeloablative therapy required to eliminate the basic disease and to prevent allograft rejection. After bone marrow transplantation, these patients remain profo